Cassava Sciences | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Abbott USD 25.15B 133M 2024-12
Amgen USD 33.53B 140M 2024-12
Biogen USD 100K 0 2024-12
Cassava Sciences USD 48K 0 2024-12
Eisai JPY 44.99B 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Geron USD 606K 3K 2024-12
J&J USD 3.12B 0 2024-12
Merck USD 1.79B 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 480M 0 2024-12
Roche Holding CHF 107M 0 2024-06



Cassava Sciences Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.